11-99819552-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014361.4(CNTN5):āc.64A>Gā(p.Lys22Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000869 in 1,610,570 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_014361.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CNTN5 | NM_014361.4 | c.64A>G | p.Lys22Glu | missense_variant | 4/25 | ENST00000524871.6 | NP_055176.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNTN5 | ENST00000524871.6 | c.64A>G | p.Lys22Glu | missense_variant | 4/25 | 1 | NM_014361.4 | ENSP00000435637.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152232Hom.: 0 Cov.: 37
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 247564Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134918
GnomAD4 exome AF: 0.00000754 AC: 11AN: 1458220Hom.: 0 Cov.: 28 AF XY: 0.00000551 AC XY: 4AN XY: 725554
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152350Hom.: 0 Cov.: 37 AF XY: 0.0000268 AC XY: 2AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 26, 2024 | The c.64A>G (p.K22E) alteration is located in exon 1 (coding exon 1) of the CNTN5 gene. This alteration results from a A to G substitution at nucleotide position 64, causing the lysine (K) at amino acid position 22 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at